All In Biotech

Free tool

Medicare drug spending

CMS's Spending by Drug data: what Medicare paid for each drug before manufacturer rebates. Part D covers drugs dispensed by pharmacies; Part B covers drugs given in a doctor's office or hospital outpatient department. Commercial and list prices are not public data and are not shown.

Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations

Part D, 2024

$288.7B

Gross drug spending in the dataset

Part B, 2024

$60.8B

Gross drug spending in the dataset

Drugs listed

799

Part B

Total spending by year

  • Part D
  • Part B
View as table
YearPart DPart B
2020$194,092,038,339$37,778,829,680
2021$213,513,349,361$40,135,340,775
2022$239,779,215,689$44,241,259,745
2023$275,808,918,753$50,775,853,083
2024$288,667,842,058$60,838,164,403
Reset

Top 100 by total spending

2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.

DrugPartSpendingChangeBeneficiariesPer beneficiaryPer unit
Keytruda

Pembrolizumab · J9271

B$5.99B+10%75,361$79,464$55.72
Darzalex Faspro

Daratumumab-Hyaluronidase-Fihj · J9144

B$2.53B+22%26,517$95,426$49.11
Prolia*

Denosumab* · J0897

B$2.43B+11%700,724$3,469$25.47
Eylea

Aflibercept · J0178

B$2.37B-25%293,280$8,065$825.90
Opdivo

Nivolumab · J9299

B$1.93B+1%26,951$71,752$30.71
Vabysmo

Faricimab-Svoa · J2777

B$1.92B+48%172,503$11,120$34.47
Membrane graft or membrane wrap, per square centimeter

· Q4205

B$1.44B+325%10,459$137,893$1,302.54
Complete ft, per square centimeter

· Q4271

B$1.17B+18769%5,091$229,484$1,636.66
Orencia*

Abatacept* · J0129

B$930M+3%33,154$28,062$42.48
Imfinzi

Durvalumab · J9173

B$843M+14%14,791$56,999$79.68
Entyvio

Vedolizumab · J3380

B$769M+6%19,661$39,134$21.79
Gammagard Liquid

Immun Glob G(Igg)/Gly/Iga Ov50 · J1569

B$765M+3%26,102$29,310$44.60
Reblozyl

Luspatercept-Aamt · J0896

B$755M+67%6,466$116,808$39.53
Restorigin, per square centimeter

· Q4191

B$732M+30150%5,256$139,204$1,481.65
Comirnaty *

Covid Vac (12up)(Raxt)/PF* · 91320

B$696M+58%4,283,296$163$143.04
Tecentriq

Atezolizumab · J9022

B$678M-10%10,191$66,497$83.43
Ocrevus

Ocrelizumab · J2350

B$669M-4%11,764$56,845$57.58
Eylea Hd

Aflibercept · J0177

B$666Mn/a66,767$9,972$330.00
Padcev

Enfortumab Vedotin-Ejfv · J9177

B$641M+106%5,839$109,818$35.32
Evenity (2 Syringes)

Romosozumab-Aqqg · J3111

B$639M+42%52,146$12,261$10.73
Helicoll, per square centimeter

· Q4164

B$637M+1143%2,421$263,250$1,521.68
Ultomiris

Ravulizumab-Cwvz · J1303

B$609M+29%1,844$330,448$215.41
Spikevax

Covid Vac (12up)(Andu)/PF · 91322

B$597M+17%3,479,068$172$152.66
Enhertu

Fam-Trastuzumab Deruxtecn-Nxki · J9358

B$581M+25%8,410$69,140$26.95
Fluzone High-Dose *

Flu Vacc TS(65yr Up)/PF* · 90662

B$560M+31%6,956,496$81$79.62
Gammaked*

Immune Globul G/Gly/Iga Avg 46* · J1561

B$545M+18%15,316$35,580$48.29
Prevnar 20

Pneumoc 20-Val Conj-Dip Crm/PF · 90677

B$525M-9%1,840,975$285$282.44
Yervoy

Ipilimumab · J9228

B$509M+11%8,483$59,960$170.60
Botox*

Onabotulinumtoxina* · J0585

B$479M+8%165,103$2,899$6.22
Actemra (J3262)

Tocilizumab · J3262

B$463M+11%19,715$23,495$5.89
Sandostatin Lar Depot

Octreotide Acetate,mi-Spheres · J2353

B$450M+1%8,853$50,884$208.42
Privigen

Immun Glob G(Igg)/Pro/Iga 0-50 · J1459

B$440M+17%13,330$33,026$47.21
Rituxan

Rituximab · J9312

B$437M-10%22,261$19,630$76.27
Vyvgart

Efgartigimod Alfa-Fcab · J9332

B$417M+40%1,803$231,053$31.47
Xolair

Omalizumab · J2357

B$415M-1%17,605$23,566$37.24
Ilumya

Tildrakizumab-Asmn · J3245

B$413M+20%9,049$45,684$134.38
Syfovre

Pegcetacoplan/PF · J2781

B$404M+427%29,338$13,766$146.80
Cimzia*

Certolizumab Pegol* · J0717

B$398M-1%25,557$15,559$4.55
Kyprolis

Carfilzomib · J9047

B$397M-1%5,806$68,327$47.38
Infliximab*

Infliximab* · J1745

B$367M-6%36,967$9,919$31.30
NPlate

Romiplostim · J2796

B$362M+12%6,523$55,572$96.80
Opdualag

Nivolumab-Relatlimab-Rmbw · J9298

B$362M+43%2,535$142,849$184.36
Lanreotide Acetate (J1930)*

Lanreotide Acetate* · J1930

B$354M-4%7,615$46,454$48.23
Libtayo

Cemiplimab-Rwlc · J9119

B$348M+29%5,482$63,500$27.11
Soliris

Eculizumab · J1300

B$337M-19%956$352,952$219.00
Simponi Aria

Golimumab · J1602

B$330M-10%33,452$9,865$11.44
Dual layer impax membrane, per square centimeter

· Q4262

B$318M-77%1,678$189,626$1,093.57
Hizentra

Immun Glob G(Igg)/Pro/Iga 0-50 · J1559

B$318M+8%5,165$61,539$12.84
Membrane wrap-hydro, per square centimeter

· Q4290

B$310Mn/a1,807$171,399$1,898.83
Fluad *

Flu Vacc TS(65up)/Mf59c/PF* · 90653

B$303M+113287%3,768,112$80$80.30
Perjeta

Pertuzumab · J9306

B$297M-4%5,766$51,528$15.40
Leqvio

Inclisiran Sodium · J1306

B$296M+107%48,298$6,135$11.95
Krystexxa

Pegloticase · J2507

B$283M+15%1,097$257,821$3,319.64
Amnicore pro+, per square centimeter

· Q4299

B$281Mn/a1,474$190,882$2,367.31
Neostim tl, per square centimeter

· Q4265

B$274Mn/a1,202$228,090$2,073.58
Trodelvy

Sacituzumab Govitecan-Hziy · J9317

B$272M+18%3,300$82,521$33.76
Nucala

Mepolizumab · J2182

B$267M+5%8,671$30,829$29.70
Abraxane*

Paclitaxel Protein-Bound* · J9264

B$263M-7%13,324$19,747$13.38
Amnio quad-core, per square centimeter

· Q4294

B$248Mn/a1,400$176,909$2,206.87
Tepezza

Teprotumumab-Trbw · J3241

B$246M-10%962$256,201$321.05
Fasenra*

Benralizumab* · J0517

B$241M+4%9,899$24,374$163.35
Orion, per square centimeter

· Q4276

B$235M+184%984$238,833$1,330.78
Complete aa, per square centimeter

· Q4303

B$233Mn/a548$424,998$3,298.76
Amnio-maxx or amnio-maxx lite, per square centimeter

· Q4239

B$232M+61497%1,858$124,681$2,387.81
Hemlibra

Emicizumab-Kxwh · J7170

B$230M-1%438$525,221$52.49
Octagam

Immun Globg(Igg)/Malt/Iga Ov50 · J1568

B$230M+15%8,749$26,251$45.92
Amvuttra

Vutrisiran Sodium · J0225

B$229M+37%603$379,824$4,787.75
Tezspire

Tezepelumab-Ekko · J2356

B$218M+58%7,618$28,676$17.78
Cimerli

Ranibizumab-Eqrn · Q5128

B$217M+77%38,028$5,703$228.24
Eligard*

Leuprolide Acetate* · J9217

B$213M-1%141,546$1,506$177.55
Elahere

Mirvetuximab Soravtansine-Gynx · J9063

B$213M+141%1,757$121,204$64.92
Derm-maxx, per square centimeter

· Q4238

B$204M+5422%1,150$177,815$1,149.16
Polivy

Polatuzumab Vedotin-Piiq · J9309

B$202M+69%3,042$66,241$124.68
Tecvayli

Teclistamab-Cqyv · J9380

B$200M+127%1,549$129,048$30.74
Izervay

Avacincaptad Pegol Sodium/PF · J2782

B$190Mn/a18,308$10,398$108.34
Adcetris

Brentuximab Vedotin · J9042

B$187M-3%1,363$137,180$230.36
Amniowrap2, per square centimeter

· Q4221

B$184M+585%1,010$182,393$1,755.69
Gazyva

Obinutuzumab · J9301

B$184M+13%5,252$34,943$70.96
Tyvaso*

Treprostinil* · J7686

B$183M-11%1,226$149,284$730.43
Yupelri

Revefenacin · J7677

B$175M+1%29,240$5,987$0.18
Xwrap, per square centimeter

· Q4204

B$164M+409%928$176,846$2,807.89
Avastin

Bevacizumab · J9035

B$162M-23%98,961$1,632$71.33
Tysabri

Natalizumab · J2323

B$159M-14%2,778$57,169$23.41
Cygnus dual, per square centimeter

· Q4282

B$158M+692%3,107$50,868$764.38
Amnio tri-core amniotic, per square centimeter

· Q4295

B$158Mn/a1,143$138,132$1,938.93
Erbitux

Cetuximab · J9055

B$158M+1%3,387$46,542$72.98
Aranesp (J0881)

Darbepoetin Alfa In Polysorbat · J0881

B$152M-3%39,338$3,859$2.93
Vyvgart Hytrulo

Efgartigimod-Hyaluronidas-Qvfc · J9334

B$151Mn/a902$167,216$32.40
Darzalex

Daratumumab · J9145

B$150M-32%2,246$66,731$61.49
Jemperli

Dostarlimab-Gxly · J9272

B$142M+295%1,770$80,337$230.86
Kadcyla

Ado-Trastuzumab Emtansine · J9354

B$142M-2%2,206$64,448$38.53
Mvasi

Bevacizumab-Awwb · Q5107

B$141M-13%13,212$10,697$25.83
Cyramza

Ramucirumab · J9308

B$138M+3%3,080$44,726$68.94
Vectibix

Panitumumab · J9303

B$137M+4%2,636$51,946$152.35
Aralast NP*

Alpha-1-Proteinase Inhibitor* · J0256

B$131M+4%1,389$94,506$4.78
Injectafer

Ferric Carboxymaltose · J1439

B$131M-11%73,218$1,793$1.10
Lucentis

Ranibizumab · J2778

B$129M-67%33,741$3,821$159.40
Truxima

Rituximab-Abbs · Q5115

B$127M-27%15,052$8,421$32.90
Benlysta

Belimumab · J0490

B$126M+6%3,685$34,064$52.31
Phesgo

Pertuzumab-Trastuzumab-Hy-Zzxf · J9316

B$125M+35%2,301$54,234$64.44

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.